Julie Waras Brogren, Deputy CEO will present Q3 2024 results. To register to the event: Ascelia Pharma - What Happened During Q3 2024

Ascelia Pharma will be at the Jefferies Healthcare conference.

Ascelia Pharma will present Orviglance SPARKLE study primary results as oral presentation in cutting edge research at the 2024 RSNA annual meeting. Timing of presentation: 2 Dec, 13:30-14:00 CDT, local time Chicago  

Ascelia Pharma will present at the institutional investor seminar, to register: investor seminar registration

Ascelia Pharma will present at the Redeye Fight Cancer Event. You can send in your question: Ask your questions

Julie Waras Brogren will present the full year and Q4 2024. To register: Ascelia Pharma – Presentation of Full year and Q4 report

Magnus Corfitzen will present at Carnegie Healthcare day.

Magnus Corfitzen will present at the ØU Life Science conference. To  register: Investor event - 26 March   

Interview with Magnus Corfitzen, to join the live event: Ascelia Pharma - Interview

Magnus Corfitzen, CEO will be presenting at ABG Sundall Collier.

Julie Waras Brogren, Deputy CEO will  present the Q1 2025 results. To register:  First quarter 2025

Ascelia Pharma will present the financial results for H1 2025. To register: H1 2025 results - 22 August at 10:00

Invitation to investor event: Market trends in Nordic healthcare equities – featuring presentations by DNB Carnegie, BioPorto Diagnostics A/S & Ascelia Pharma AB Niels Granholm-Leth, Head of Equity Research DNB Carnegie will open the event with an overview of trends and performance in Nordic healthcare equities. Julie Waras Brogren, Deputy CEO, presents Ascelia Pharma and, […]

Deputy CEO Julie Waras Brogren will present the Q3 2025 results at a virtual live event for investors. To register: Q3 2025 presentation

Magnus Corfitzen, CEO at Ascelia Pharma will be presenting at the Small Cap Day at DNB Carnegie. The event will take place at DNB Carnegie Hall in Stockholm, with both physical attendance and livestreaming: Small Cap Day - DNB Carnegie

Andreas Norlin, Chief Scientific Officer will be presenting at Redeye Life Science day in Stockholm. You can already submit your questions: Redeye - Ascelia Pharma

Magnus Corfitzen will present at ABGSC’s Investor Days Seminar on December 4.